SCHEMBL7130790

SCHEMBL7130790

CC(C)(C)ON(C=O)c1ccsc1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
RAB9A P51151 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
AXL P30530 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KMT2A Q03164 3/20 0.35
PTPN2 P17706 1/20 0.34
PTPN1 P18031 1/20 0.34
ABCC1 P33527 1/20 0.33
MEN1 O00255 2/20 0.33
NPC1 O15118 1/20 0.33
FABP4 P15090 4/20 0.31
FABP3 P05413 1/20 0.31
FABP2 P12104 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4371249 0.78
SCHEMBL22261624 0.74 LMNA (0.44) LMNARAB9AL3MBTL1KDM4EALDH1A1
SCHEMBL6856498 0.74 LMNA (0.40) LMNAKDM4EALDH1A1GAAHPGD
SCHEMBL4380483 0.71
SCHEMBL9865850 0.71 HTT (0.43) RAB9AL3MBTL1KDM4EALDH1A1GAA
SCHEMBL8816297 0.70 ALDH1A1 (0.40) L3MBTL1ALDH1A1GLAHPGDKMT2A
SCHEMBL3907258 0.70 AXL (0.44) LMNARAB9AL3MBTL1KDM4EALDH1A1
SCHEMBL6837728 0.70 KDM4C (0.38) RAB9AL3MBTL1KDM4EALDH1A1GLA
SCHEMBL3664675 0.68 ALDH1A1 (0.41) RAB9AKDM4EALDH1A1GAAHPGD
SCHEMBL11659943 0.67 RAB9A (0.54) LMNARAB9AL3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1313464-C Substituted alkylamine derivatives and methods of use AMGEN INC (US) 2007-05-02 CN disclosed
EP-1358184-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE Amgen Inc. (US) 2003-11-05 EP disclosed
WO-2002066470-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2002-08-29 WO disclosed